These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16785849

  • 1. Adult immunization.
    Treat Guidel Med Lett; 2006 Jul; 4(47):47-54. PubMed ID: 16785849
    [No Abstract] [Full Text] [Related]

  • 2. Adult immunization.
    Treat Guidel Med Lett; 2014 Jun; 12(142):39-48. PubMed ID: 24869519
    [No Abstract] [Full Text] [Related]

  • 3. Routine vaccines across the life span, 2005.
    Zimmerman RK, Middleton DB, Burns IT, Clover RD, Kimmel SR.
    J Fam Pract; 2005 Jan; 54(1 Suppl):S9-26. PubMed ID: 15623396
    [Abstract] [Full Text] [Related]

  • 4. Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds.
    Cassidy WM, Jones G, Williams K, Deforest A, Forghani B, Virella G, Venters C.
    J Adolesc Health; 2005 Mar; 36(3):187-92. PubMed ID: 15737773
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L, Hongtao H, Shunqin W, Jinping G, Jiandong C, Zhaoliang L, Xinwen F.
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM, LAIV Study Group.
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [Abstract] [Full Text] [Related]

  • 7. Vaccination guidelines for female infertility patients.
    Practice Committee of American Society for Reproductive Medicine.
    Fertil Steril; 2008 Nov; 90(5 Suppl):S169-71. PubMed ID: 19007619
    [Abstract] [Full Text] [Related]

  • 8. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, Douha M, Willems P.
    Vaccine; 2009 May 05; 27(20):2701-6. PubMed ID: 19428882
    [Abstract] [Full Text] [Related]

  • 9. A comprehensive patient assessment and physician reminder tool for adult immunization: effect on vaccine administration.
    Fishbein DB, Willis BC, Cassidy WM, Marioneaux D, Winston CA.
    Vaccine; 2006 May 01; 24(18):3971-83. PubMed ID: 16569468
    [Abstract] [Full Text] [Related]

  • 10. Systemic allergic reactions to gelatin included in vaccines as a stabilizer.
    Sakaguchi M, Inouye S.
    Jpn J Infect Dis; 2000 Oct 01; 53(5):189-95. PubMed ID: 11135703
    [Abstract] [Full Text] [Related]

  • 11. Have your vaccinations had a check-up lately? Don't assume vaccinations received during childhood will protect you for the rest of your life.
    Harv Womens Health Watch; 2009 Feb 01; 16(6):6-7. PubMed ID: 19297746
    [No Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses.
    Rümke HC, Loch HP, Hoppenbrouwers K, Vandermeulen C, Malfroot A, Helm K, Douha M, Willems P.
    Vaccine; 2011 May 17; 29(22):3842-9. PubMed ID: 21382484
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb 17; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y, Steri GC, Behre U, Arsène JP, Lanse X, Helm K, Esposito S, Meister N, Desole MG, Douha M, Willems P.
    Vaccine; 2009 Jan 14; 27(3):446-53. PubMed ID: 19007835
    [Abstract] [Full Text] [Related]

  • 15. New "4-way" vaccine approved...and do multiple vaccines increase immune problems?
    Child Health Alert; 2005 Oct 14; 23():1-2. PubMed ID: 16294374
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Laws HJ, Calaminus G, Göbel U.
    Cancer; 2005 Apr 15; 103(8):1759; author reply 1760. PubMed ID: 15717299
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Fioredda F, Giacchino M, Castagnola E.
    Cancer; 2005 Apr 15; 103(8):1758-9; author reply 1760. PubMed ID: 15717298
    [No Abstract] [Full Text] [Related]

  • 18. Immunizations for HIV-infected adults: indications, timing, and response.
    Spach DH.
    Top HIV Med; 2005 Apr 15; 14(5):154-8. PubMed ID: 17237556
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P, Lim FS, Han HH, Willems P.
    Infection; 2007 Oct 15; 35(5):326-33. PubMed ID: 17710370
    [Abstract] [Full Text] [Related]

  • 20. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT, Boohene PA, Mowrer A, Audet S, Menegus MA, Schmid DS, Beeler JA.
    Pediatrics; 2007 Mar 15; 119(3):e574-9. PubMed ID: 17332177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.